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EIA (Equine Infectious Anemia) is a blood-borne disease primarily transmitted by haematophagous insects or
needle punctures. Other routes of transmission have been poorly explored. We evaluated the potential of EIAV
(Equine Infectious Anemia Virus) to induce pulmonary lesions in naturally infected equids. Lungs from 77 EIAV
seropositive horses have been collected in Romania and France. Three types of lesions have been scored on
paraffin-embedded lungs: lymphocyte infiltration, bronchiolar inflammation, and thickness of the alveolar septa.
Expression of the p26 EIAV capsid (CA) protein has been evaluated by immunostaining. Compared to EIAV-negative
horses, 52% of the EIAV-positive horses displayed a mild inflammation around the bronchioles, 22% had a moderate
inflammation with inflammatory cells inside the wall and epithelial bronchiolar hyperplasia and 6.5% had a moderate to
severe inflammation, with destruction of the bronchiolar epithelium and accumulation of smooth muscle cells within
the pulmonary parenchyma. Changes in the thickness of the alveolar septa were also present. Expression of EIAV capsid
has been evidenced in macrophages, endothelial as well as in alveolar and bronchiolar epithelial cells, as determined
by their morphology and localization. To summarize, we found lesions of interstitial lung disease similar to that
observed during other lentiviral infections such as FIV in cats, SRLV in sheep and goats or HIV in children. The presence
of EIAV capsid in lung epithelial cells suggests that EIAV might be responsible for the broncho-interstitial damages
observed.Introduction
Equine Infectious Anemia Virus (EIAV) is a retrovirus be-
longing to the lentivirus genus, which infects equids world-
wide (reviewed in [1]). Persistent infection is characterized
by recurring viremic febrile episodes. Clinical signs of EIA
(Equine Infectious Anemia), the EIAV-induced disease, are
variable although infected equids often experience acute
febrile episodes with concomitant thrombocytopenia and
wasting syndrome followed by a chronic stage character-
ized by recurring disease episodes. In most cases, these fe-
brile episodes eventually cease and despite remaining
persistently infected the animals enter a prolonged phase
with no overt clinical signs (reviewed in [1]). These in-
apparent carriers are potential reservoirs for transmission
to naive equids. Despite a sanitary policy including culling* Correspondence: caroline.leroux@univ-lyon1.fr
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reproduction in any medium, provided the orof the seropositive animals and serological survey of all the
in-contact horses, the disease still spreads among horses.
EIAV infection is endemic in horse populations through-
out the world [2] including recent outbreaks in Belgium,
Germany, Greece, France, Italy, Romania and UK (source
OIE reports). Romania had to deal with more than 10 000
infected horses over the 2009–2012 period [3]. Relatively
little is known about the origins, the viral characterization
and the pandemic spread of the viruses [4,5].
In experimentally-infected equids, active viral replication
has been detected in various tissues such as spleen, liver,
lung, lymph nodes or bone marrow (reviewed in [1]), and
viral tropism for mononuclear phagocytes is widely ac-
cepted. As for other human and animal lentiviruses, the
cells of the monocyte/macrophage lineage represent the
main targets of EIAV in vivo, supporting active viral repli-
cation during clinical and subclinical infection [6]. EIAV
viral RNAs have been also detected in vascular endothelial
cells in experimentally infected horses during the acuted. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in the development of oxidative stress in horses [8].
We hypothesized that, as demonstrated with other len-
tiviruses, EIAV may induced specific lung lesions. We
systematically characterized lung lesions from paraffin
embedded sections collected from 93 Romanian and
French horses. We stained the lung for the expression of
EIAV p26 capsid protein. In this study we described for
the first time an interstitial lung disease in EIAV infected
horses as well as infection of lung epithelial cells.
Materials and methods
Animal source and tissue specimens
Lungs from 93 horses have been collected for this study.
Seventy nine lungs (# 1 to 79) came from EIAV-positive
(EIAVPOS) horses, mean age 10.65 years (± 5.43) and from
14 EIAV-negative (EIAVNEG) horses (# 80 to 93), mean age
9.73 years (± 5.14). Among the EIAVPOS horses, 77 (31 fe-
males and 46 males, mean age 10.58 years (± 5.47)) have
been collected in Romania (-rom) from October 2010 to
May 2011. They were serologically positive for EIAV as
confirmed by agar gel immunodiffusion test (AGID) or
Coggins test (EIA Kit No. 119, Pasteur Institute) performed
by regional reference laboratories across the country in the
context of the wide range National survey of EIAV in-
fection among farm horses. Positive animals have been put
to death according to the national plan for eradication of
EIA in Romania (Order No. 52/09.06.2010, ANSVSA
Bucharest, Romania). At that time, none of these animals
displayed clinical signs of EIA nor pulmonary disease as
assessed by a rapid examination; importantly no biologi-
cal parameters (body temperature or blood cell counts)
have been collected. Lungs from 2 EIAVPOS French horses
(78-fr, 10 year-old female and 79-fr, 16-year old male) have
been collected on April 2005 (kindly provided by Dr Stephan
Zientara, Veterinary school, Maisons-Alfort, France).
Fourteen EIAVNEG horses, 7 males and 7 females
(mean age 9.92 (± 4.94)), have been collected in France
(-fr) and Romania (-rom). Five of these came from
Romanian slaughterhouses (3 females and 2 males, mean
age 9.00 years (± 6.06)) and nine French horses (mean
age 10.14 years (± 5.01)) have been put to death at the
Veterinary School of Lyon for colic (n = 6), septic shock
(n = 2) or inguinal abscess (n = 1). While the EIAV sero-
logical status has been confirmed for the Romanian ani-
mals, none of the French horses have been serologically
tested for EIAV. France does not have a wide range Na-
tional survey of EIAV infection and the AGID is only per-
formed for suspected animals presenting with clinical
signs relevant to EIA or on “in-contact” animals with an
already confirmed EIAVPOS animal. But importantly, none
of the French EIAVNEG horses had symptoms associated
with EIAV and the prevalence in France being low, we
considered these animals EIAVNEG and associated them tothe Romanian EIAVNEG horses to constitute the control
group.
Pathology
Lungs were sampled from the mid dorsal part of the caudal
lobe. Samples were fixed in 10% neutral buffered formalin
for at least 24 h at 4 °C, dehydrated in ascending concen-
trations (70, 95 and 100%) of ethanol, cleared in xylene,
and embedded in Histowax (Histo-Lab. Ltd, Gothenburg,
Sweden). Five μm thick serial sections were cut, deparaffi-
nized, rehydrated with water in descending concentrations
of ethanol (100, 95 and 70%) and used for HE (hematoxylin
and eosin) staining. Tissues were observed under a light
microscope and a score was assigned according to the se-
verity of the lesions, by blinded reading of the lung slides,
accordingly to previously reported studies on the SRLV-
induced interstitial lung disease in sheep [9-11]. Three
types of lesions have been evaluated: lymphocyte infiltra-
tion i.e. presence or absence of inflammatory cells in the
lung parenchyma [A], (peri)bronchiolar inflammation [B]
and thickness of the alveolar septa [C]. The bronchiolar in-
flammation was evaluated per ten random microscopic
fields using a magnification of X100 and included five cat-
egories: “0” for no lesions; “I” for mild lymphocyte inflam-
mation around bronchiole; “II” for moderate lymphocyte
infiltration around bronchiole and inside wall, epithelial
bronchiolar hyperplasia; “III” for moderate to severe
lymphocyte infiltration, partial destruction of bronchiolar
epithelium, peribronchiolar muscle cells more visible and
“IV” for destruction of bronchiolar lumen or epithelium re-
placed by fibrous/muscular layers with or without inflam-
matory cells. The thickening of the alveolar septa was
evaluated according to the degree of interstitial accumula-
tion of inflammatory cells and exudate and included four
categories: “0” for no change, “I” for multifocal interstitial
leukocytes without protein exudate, “II” for multifocal and
intermittent confluent areas of leukocyte infiltration, with
or without interstitial protein exudates and “III” for conflu-
ent areas of alveolar septal thickening with leukocytes and
protein exudates.
For each horse, a lung pathology score was estimated
using the [(B + C)/2] formula taking into account the se-
verity of (peri)bronchiolar inflammation [B] and thick-
ness of the alveolar septa [C] as previously reported
[9-11]. This score was used to sort the horses according
to the severity of the observed lung pathology where 0
to 0.4 means lesions, 0.5 to 1.4 defined mild lesions, 1.5
to 2.4 defined moderate lesions and >2.4 defines severe
lesions.
Expression of αSMA and p26 EIAV capsid (CA) evaluated
by immunofluorescence on lung tissues
Four μm thick sections from paraffin embedded lungs
were cut and placed on superfrost glass slides. All
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washes and rehydrated through 100%, 90% and 75% etha-
nol baths. Tissues were rinsed with tap water and PBS for
30 min and blocked with 5% normal horse serum, 1%
bovine serum albumin in PBS for 30 min at room
temperature. The mouse anti-αSMA (alpha Smooth
Muscle Actin) (Sigma) and the mouse anti-EIAV core
antigen p26 (clone EIAV 12E8.1 MAB10206, Millipore)
antibodies were respectively diluted at 1/500 and 1/50 inFigure 1 Grading of the histological lesions from lung sections. A. Ab
horse (#91-rom). B. Mild lesions of broncho-interstitial pneumonia in an EIAVPOS
accumulation with mild thickening of the interlobular septa. C. Moderate lesion
septa and moderate thickening of the alveolar walls. D. Severe lesions of interst
infiltration, partial destruction of bronchiolar epithelium, peribronchiolar accumu
alveolar septal leukocyte exudate. (►) Interstitial lymphocyte accumulation; (✶)
peribronchiolar accumulation of smooth muscle cells; a: alveoli; b: bronchiole.PBS. After overnight incubation at 4 °C, tissue sections
were rinsed twice with PBS and incubated for 30 min, in
the dark, with 1/500 dilution of goat anti-mouse IgG
Dylight488 (Eurobio) or goat anti-mouse IgG Dylight 594
(Eurobio). Tissue sections were rapidly rinsed twice with
PBS and incubated with DAPI (Fluka) for 10 min at room
temperature in the dark. Sections were rinsed twice with
PBS and covered with fluoromount before microscopic
examination.sence of histological lesion in the lung parenchyma of an EIAVNEG
horse (#1-rom) revealed peribronchiolar and interstitial lymphocytic
s in EIAVPOS horse (#78-fr) with accumulation of lymphocytes within the
itial pneumonia in EIAVPOS horse (# 2-rom) with peribronchiolar lymphocyte
lation of smooth muscle cells and thickening and partial destruction of the
thickening of the interlobular septa; (➔) destruction of alveolar walls; ( )



















Histological score* [(B + C)/2]
No lesions 0 (0–0.4) 13 11
Mild lesions I (0.5-1.4) 35 3
Moderate lesions II (1.5-2.4) 27 0
Severe lesions III (>2.4) 4 0
Mean score: 1.09 0.17
Pulmonary lesions have been blindly observed and graded according to
their severity from EIAV-positive (EIAVPOS) and EIAVnegative (EIAVNEG) horses.
[A] described the presence of infiltrating lymphocytes. [B] described the type
and the severity of (peri) bronchiolar inflammation; [C] described the thickness of
the septa and its severity; * total histological score was calculated using the
[(B + C)/2] formula. The histological score allows the ranking of the pulmonary
disease where 0 to 0.4 means no lesions, 0.5-1.4 mild lesions, 1.5-2.4 moderate
lesions and >2.4 severe lesions.
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Splenic tissues from an non-infected and a naturally
EIAV-infected French mare were lysed in 0.5 M Tris
pH 8.0, 10% glycerol, 150 mM NaCl, 1% Triton X-100,
5 mM EDTA, 1 mM Na3VO4, 1 mM PMSF, 10 mg/mL
leupeptin, 10 mg/mL, homogenized with the “Fastprep
system device” (Qbiogene) and incubated for 30 min on
ice. Forty μg of proteins were separated on a 15% SDS
PAGE and transferred onto a 0.2-mM nitrocellulose mem-
brane (Biorad). The membranes were pre-incubated with
TSBT (25 mM Tris pH 7.6; 0.15 M NaCl; 0.05% Tween
20) containing 5% non-fat dry milk for 1 h at room
temperature. After three washes in TSBT, the membrane
was incubated for 1 h at room temperature with a 1/1000
dilution of the anti-p26 antibody, washed in TBST and in-
cubated for an hour at room temperature with a 1/30 000
dilution of the anti-mouse IgG (whole molecule)-peroxi-
dase antibody (Sigma). The immunoreactive bands were de-
tected using the “Supersignal West Pico” reagent (Perbio).
Results
Lesions consistent with interstitial lung disease are
present in EIAVPOS horses
In contrast to the EIAVNEG horses (Figure 1A), 52% of the
EIAVPOS horses displayed a mild inflammation around the
bronchioles (Figure 1B), 21.5% had moderate inflammation
with inflammatory cells inside the alveolar wall and areas of
epithelial bronchiolar hyperplasia (Figure 1C), and 6.3%
had moderate to severe inflammation, with destruction of
the bronchiolar epithelium and accumulation of smooth
muscle cells (Figure 1D). Severe inflammation was present
only in one horse (#16-rom) with absence of bronchial epi-
thelium, replaced by fibromuscular layers with dispersed
inflammatory cells. Among the EIAVNEG horses only 3 of
the 15 animals (21.4%) presented with mild inflammatory
changes in the (peri)bronchiolar area. Changes in the thick-
ness of the alveolar septa were present in the EIAVPOS ani-
mals. Considering this group, over 40% presented with
multiple foci of mainly mononuclear cells in the septa and
26.6% displayed multifocal and intermittent confluent areas
of leukocyte infiltration, without interstitial protein exudate.
Among these EIAVPOS horses, 30% had no change regard-
ing the thickness of septa. Except for one horse showing
limited thickness and mononuclear cell infiltration into the
septa, lesions were absent in the EIAVNEG control group.
Taking together, pulmonary lesions characterized by
lymphocyte infiltration, (peri)bronchiolar inflammation
and thickness of the septa were present in most EIAVPOS
horses (Table 1, Figure 1). Only mild lesions of bronchi-
olar or peribronchiolar inflammation and limited thick-
ness of the alveolar septa have been observed in the
EIAVNEG animals. After the blind observation of all the
93 lung sections and the determination of the histo-
logical score defined by [(bronchiolar/peribronchiolarinflammation + thickness of the alveolar septa)/2], 83%
of the EIAVPOS horses developed mild to severe lung le-
sions defined by a score above 0.4. In contrast, only 21%
of animals from the EIAVNEG group had mild lesions
with a score under 1.5, with no animal with moderate or
severe lesions (Table 1, Figure 2).
Smooth-muscle cells accumulation within the lung par-
enchyma has been observed in 8 EIAVPOS-horses (10.13%)
(Figure 3A). In these animals, the inflammation and de-
struction of the bronchiolar architecture were accom-
panied by smooth muscle hyperplasia or proliferation
centrifugally starting from a bronchiole, accompanied by
bronchiolar metaplasia of alveoli. Immunostaining with
anti-αSMA antibodies evidenced large cells with organized
reticulated actin- fibers (Figures 3B and 3C).
The EIAV p26 capsid protein is expressed in the equine
pulmonary cells
In order to associate the observed lesions with the expres-
sion of the EIAV viral protein, immunostainings for the
p26 capsid protein using a monoclonal anti-p26 antibody
have been performed on lung sections from EIAVNEG and
EIAVPOS horses. Specificity of the anti-p26 antibody has
Figure 2 Distribution of interstitial lung lesions in horses according to their EIAV status. The histological scores are reported for the
EIAVPOS and EIAVNEG populations. This score was used to sort the horses according to the severity of the observed lung pathology where 0 to 0.4
means no lesions, 0.5 to 1.4 mild lesions, 1.5 to 2.4 moderate lesions and > 2.4 severe lesions. N: number of horses.
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extracts from EIAVPOS French horses with the detection
of both the p26 CA and the PR55gag precursor (data not
shown).
The p26 capsid was expressed in the infiltrated mono-
nuclear cells within the alveolar septa (Figure 4A) and
into endothelial cells of the blood vessels (Figure 4B).
Interestingly, EIAV p26 was also expressed in cells con-
sistent by their morphology and localization into the
lung parenchyma with alveolar and bronchiolar epithelial
cells such as type I and type II alveolar epithelial cells
(AECI and AECII) in the alveoli (Figure 4C) and club
cells (Clara) in the bronchiole (Figure 4D). These epithe-
lial cells expressed p26 capsid in their cytoplasm, with a
dotted pattern corresponding to local accumulation of
protein (Figure 4C). Despite several attempts, pheno-
typic characterization of AECII by their expression of
SP-C (Surfactant Protein C) failed, due to non-specific
cross reaction with the tested antibodies (not shown).
Discussion
We explored the potential of EIAV to induce pulmonary
lesions in naturally infected equids from 79 EIAV-
seropositive horses collected in Romania and France. We
scored three types of lesions on paraffin-embedded sec-
tions: lymphocyte infiltration, (peri)bronchiolar inflamma-
tion, and thickness of the alveolar septa and analyzed the
expression of the p26 EIAV capsid protein. Compared to
EIAV-negative horses, over 80% of the EIAV-positive ani-
mals displayed lesions of interstitial lung disease, with an
histological score above 0.4 varying from from mild inflam-
mation around the bronchioles, to moderate inflammation
with inflammatory cells inside the walls and epithelial
bronchiolar hyperplasia or severe inflammation with
destruction of the bronchiolar epithelium and accu-
mulation of smooth muscle cells within the lungparenchyma. The lesions were often localized sub-
pleurally concomitantly with metaplasia of the alveolar
epithelium, suggesting a chronic bronchiolitis. Interest-
ingly, the p26 EIAV capsid was strongly expressed in
mononuclear cells, endothelial cells as well as alveolar
and bronchiolar epithelial cells.
Smooth muscle proliferation or myomatosis was
present in over 10% of the EIAVPOS horses as evidenced
by microscopic examination of lung parenchyma and
immunostaining for the expression of α-smooth muscle
actin. Lentivirus infection of smooth muscle cells may
play a role in the induction of pathogenic events as re-
ported for myomatosis in the lung of SRLV infected
sheep [12,13], primary pulmonary hypertension and cor-
onary lesions as well as smooth muscle tumors of liver
or ileum in HIV infected individuals [14-16], or intimal
proliferation in pulmonary artery in SIV infected mon-
keys [17,18]. From the analyzed sections, we did not evi-
denced the presence of p26 into the smooth muscle
cells; the link between EIAV infection and accumulation
of smooth muscle cells needs to be further investigated.
Taking all together, the observed lesions resemble the
lung lesions associated with LIP (lymphoid interstitial
pneumonia), a lung disease described during lentivirus-
infection, and reported in child infected by HIV-1 [19],
cats infected by FIV [20,21] or sheep infected by SRLV
[12,22,23]. LIP has been reported as a direct consequence
of HIV-1 infection in humans [19] especially in child born
from seropositive mothers [24]. Pulmonary disease is the
major cause of morbidity and mortality in infants and chil-
dren infected HIV [25]. A direct role of HIV in the induc-
tion of the observed lung disease has been reported
(reviewed in [26]). Highly active antiretroviral therapy
(HAART) proved to be efficient in changing the natural
history of HIV infection in child, reducing opportunistic
infections as well as organ specific diseases such as HIV-
Figure 3 Smooth muscle cell accumulation in the lung parenchyma (horse #16-rom). A. Smooth muscle cells accumulate into the lung
parenchyma ( ) and disrupt the bronchiolar structure. Hematoxylin-eosin staining on paraffin-embedded sections. B. Immunostaining of smooth
muscle cells using an anti-αSMA antibody shows the accumulation of fusiform cells (in green) within the lung parenchyma. C. Higher magnification
shows organized actin filaments within the infiltrating cells. Nucleus are stained in blue with DAPI.
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lentivirus in the induction of the interstitial lung disease.
In SRLV-infected sheep, the severity of the lung lesions
has been correlated with the virus load [29].
We observed EIAV capsid expression in mononuclear
cells as well as in endothelial cells. In vivo, equine infec-
tious anemia virus (EIAV) replicates in macrophage-richtissues [6,30,31] and monocyte maturation controls EIAV
expression [32]. Infection of endothelial cells has been re-
ported in horses experimentally-infected with cell-adapted
EIAV strains during the acute phase [7]. Our results sug-
gest that EIAV-expression in endothelial cells is main-
tained throughout the infection, in long term infected
animals even in absence of clinical signs. Interestingly
Figure 4 Expression of EIAV p26 capsid in lung sections of EIAVPOS horses. A. Capsid expression in macrophages present in the interstitial
lung tissue from an EIAVPOS horse (#5-rom); original magnification X400; B. Capsid expression in mononuclear inflammatory cells infiltrating the
lung parenchyma around a blood vessel (v); horse #2-rom; original magnification X200; C. Capsid expression in epithelial cells of the alveolar
walls, compatible with AECII and AECI; EIAVPOS horse #5-rom; original magnification X400; D. Capsid expression in bronchiolar epithelial cells or
club cells (Clara); EIAVPOS horse #23-rom; original magnification X200; a: alveoli; b: bronchiole.
Red: p26 expression (►); blue: nucleus stained with DAPI.
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lial cells consistent with club cells in the bronchiole and
type I and II alveolar epithelial cells in the alveoli. We
failed to phenotypically characterize these cells for their
expression of specific markers such as SP-C (surfactant
protein C) or CC10 (Club cell 10 kDa) as we reported in
sheep [33], due to a high background of unspecific staining
(data not shown). Interestingly, unidentified-cells harbor-
ing EIAV have been reported in the alveolar walls of
experimentally infected horses [34]. Except the detection
of HIV-1 p24 capsid in bronchiololalveolar epithelium
[35], little is known about the interaction between thelentiviruses and these specialized epithelial cells. Interest-
ingly club cells and type II alveolar epithelial cells are the
main targets of JSRV (Jaagsiekte Sheep Retrovirus), an
oncogenic β-retrovirus responsible for the development of
a naturally occurring pulmonary adenocarcinoma in small
ruminants [33,36]. Chronic infection of alveolar and/or
bronchiolar cells is likely to play a role in the maintenance
of a chronic inflammation as it has been suggested for
interstitial lung disease related to other lentiviral infection
such as HIV. Although highly speculative, an aerosol trans-
mission occurring from EIAV-infected pulmonary cells, as
reported for SRLV [37], needs to be further estimated.
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in EIAV-infected horses associated with capsid-expression
in macrophages, endothelial as well as in mature epithelial
cells of the distal lung. The detection of infected pulmon-
ary cells and of lesions consistent with lentivirus-induced
interstitial lung disease opens the hypothesis of a virus
transmission through aerosolized particles as reported for
other retroviruses, such as SRLV or JSRV.
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